• Home
  • Search Results

Search Results

Open
Young Adult (18-34)
343 studies match your search
Open

Treatment with PUL-042 in Patients with Parainfluenza, Human Metapneumovirus, or Respiratory Syncytial Virus

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers, Leukemia, Lymphoma, Multiple Myeloma)
  • Transplant
Open

Phase 2/3 Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus

Have you been diagnosed with Metastatic Neuroendocrine Tumors or Pancreatic Cancer? If so then you may be a good fit for a clinical trial that evaluates the length of time cancer is not growing, or spreading) in participants when treated with zanzalintinib compared to everolimus.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Liver, Pancreatic)
  • Kidneys and Liver
Open

Study for a new treatment for a type of blood cancer, Acute Myeloid Leukemia (AML)

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

Age & Gender
  • 18 years ~ 60 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Zilovertamab Vedotin+R-CHP vs Polatuzumab Vedotin+R-CHP for 1L DLBCL, GCB

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Kidney Health Study

Do you or your child have a kidney condition and take certain meds? Join our study and help us make a difference! You'll also get paid for your time.

Age & Gender
  • 12 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Open

Get Real and Heel for patients with metastatic breast cancer

Join our study for people with breast cancer that may have spread to other parts of the body. You'll help us learn how exercise can help others with cancer feel better. You'll join a free 16-week exercise program. You'll fill out simple surveys and do some activity checks at the start and end.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
  • Movement
Open

Teen Stress and Loss of Enjoyment Study

Do you have a teen between 13 and 15? You and your teen can join a study about how teens feel. Your teen can earn up to $590, and you can earn up to $225 for taking part.

Age & Gender
  • 13 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Child and Teen Health
  • Healthy Volunteer or General Population
  • and 6 more
Open

Evaluating Combinations of Medications After Stem Cell Transplant to Prevent Graft versus Host Disease and Infections

Do you have leukemia, lymphoma, MDS, or MF and are preparing for a stem cell transplant from an unrelated donor? If so, you might be eligible to take part in a study that will look look at combinations of medicines given after a stem cell transplant and see how well the combinations work to prevent graft versus host disease and infection.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers, Leukemia, Lymphoma)
  • Transplant
Open

Suicide Prevention Study

Are you between the ages of 13 and 19? Have you had thoughts on giving up on life? If so, you may be able to participate in a study on a program about preventing suicide for youth and their caregivers. We hope this program can make a positive impact on their lives. Compensation is provided.

Age & Gender
  • 13 years ~ 19 years
  • Male, Female, Gender Inclusive
Study Interest
  • Mental and Emotional Health
Visit Location
100% Remote (online, phone, text)
Open

JZP598-303

Do you have metastatic HER2-positive breast cancer? if so you may be able to participate in this research study to find out whether zanidatamab combined with chemotherapy of study doctor's choice is safe and improves on the clinical benefit when compared to trastuzumab in combination with chemotherapy of study doctor's choice in treating the type of breast cancer you have.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
  • Women's Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research